Viewing Study NCT02609958


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-01 @ 2:22 PM
Study NCT ID: NCT02609958
Status: COMPLETED
Last Update Posted: 2018-05-29
First Post: 2015-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
Sponsor: ASLAN Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module